Zusammenfassung
Die großen Fortschritte in der Isolierung und Charakterisierung biologisch aktiver Proteine stellen zweifellos eines der wichtigen Merkmale der biologischen Forschung der letzten Jahrzehnte dar. Viele Eiweißstoffe, Fermente und Hormone, von deren Existenz man zum Teil schon seit langem wußte, und deren Aktivität man messend verfolgen konnte, sind in neuerer Zeit gereinigt und isoliert worden. Das Wissen um ihre chemischen und physikochemischen Eigenschaften ist heute Allgemeingut, und in vielen Fällen hat sich die Forschung bereits der ungleich schwierigeren Frage nach den Zusammenhängen von Struktur und Wirkung zugewendet.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Übersichtsarbeiten
Aggeler, P. M., J. Howard and S. P. Lucia: Platelet counts and platelet function Blood 1, 472–486 (1946).
Bessis, M.: Traité de Cytologie sanguine. Paris 1954.
Biggs, R., and R. G. Macfarlane: Human blood coagulation and its disorders. Oxford 1957.
Burstein, M., et M. Bessis: Etudes sur la physiologie des thrombocytes. Rev. Hémat. 3, 69–91 (1948).
Dausset, J.: Immunologie des plaquettes. Immuno-Hématologie Biologique et Clinique. Paris 1956.
FonioA., u. J. Schwendener: Die Thrombozyten des menschlichen Blutes. Bern 1942.
Heilmeyer, L., u. H. Begemann: Blut und Blutkrankheiten. In Handbuch der inneren Medizin, Bd. II. Berlin-Göttingen-Heidelberg 1951.
Hittmair, A.: Das Blutplättchen im Schrifttum der letzten 10 Jahre. Fol. haemat. (Lpz.) 59, 50–92 (1938).
Jürgens, R., u. E. Deutsch(Herausgeber): Hämorrhagische Diathesen. Internat. Symp. Wien 1955.
Lüscher, E. F.: Die physiologische Bedeutung der Thrombozyten. Schweiz. med. Wschr. 1956(a), 345.
Maupin, B.: Les plaquettes sanguines de Fhomme. Paris 1954.
Saltzman, G. F.: The origin of blood platelets. Acta med. scand. Suppl. 1949, 221.
Seegers, W. H.: Vue actuelle sur le rôle des plaquettes dans la coagulation sanguine. Sang 27, 866–883 (1956).
Seegers, W. H.: Symposium de la Fondation Valentino Baldacci, Pisa 1955.
Tocantins, L.: The mammalian blood platelet in health and disease. Medicine (Baltimore) 17, 155–258 (1938).
Originalarbeiten
Abramson, H. A.: Electrophoresis of the blood platelets of the horse with reference to their origin and to thrombus formation. J. exp. Med. 47, 677 (1928).
Achard, C., et M. Aynaud: Le globulin. Sem. méd. (Paris) 29, 169 (1909).
Achard, . Symposium Fondation V. Baldacci, Pisa 1959.
Adelson, E.: Mechanism of hemostatic defect caused by intravenous dextran. Clin. Res. Proc. 3, 103 (1955).
Aggeler, P. M., J. Howard and S. P. Lucia: Platelet counts and platelet function.Blood 1, 472–486 (1946).
Aggeler, P. M., S. G. White, M. B. Glendening, E. W. Page, T. B. Leakeand G. Bates: Plasma thromboplastin component (PTC)-deficiency: A new disease resembling hemophilia. Proc. Soc. exp. Biol. (N. Y.) 79, 692 (1952).
Alexander, B.: Blood cells and plasma proteins (J. L. Tullis, Edit.), p. 78. New York 1953.
Aggeler, P. M., R. Goldstein, L. Rich, A. Le Bolloch, L. K. Diamondand W. Borges: Congenital afibrinogenemia; a study of some basic aspects of coagulation. Blood 9, 843 (1954).
Alkjaersig, N., T. Abeand W. H. Seegers: Purification and quantitative determination of platelet factor 3. Amer. J. Physiol. 181, 304 (1955).
Aggeler, P. M., W. H. Seegers: Formation of prothrombin from autoprothrombin by means of liver mitochondria. Amer. J. Physiol. 183, 111 (1955).
Allen, J. G., G. Bogardus, L. O. Jacobsonand C. L. Spurr: Some observations on bleeding tendencies in thrombocytopenic purpura. Ann. intern. Med. 27, 382 (1947).
Apitz, K.: Über Profibrin: V. Die Agglutination von Blutplättchen durch Profibrin. Z. ges. exp. Med. 105, 89 (1939).
Arneth, J.: Die Blutplättchen und ihr qualitatives Blutbild. Arzt. Wschr. 1948, 225.
Astrup, T.: Fibrinolysis in the organism. Blood 11, 781 (1956).
Augustinsson, K. B., N. Datta, M. Grahnand J. Zajicek: Acetylcholinesterase in thrombocytes. Nature (Lond.) 169, 800 (1952).
Axelrod, S. L.: Some effects of ultrasonic energy upon blood coagulation. J. Lab. clin. Med. 48, 690 (1956).
Bachmann, F., F. Duckert, M. Geiger, P. Baerand F. Koller: Differentiation of the factor VII complex. Studies on the Stuart-Prower factor. Thromb. Diath. haem. 1, 169 (1957).
Bailey, K., W. T. Astburyand K. M. Rudall: Fibrinogen and fibrin as members of the keratin-myosin group. Nature (Lond.) 151, 716 (1943).
Ballerini, G.: 5-OH-triptamina e retrazione del coagulo. Progr. med. (Napoli) 11, 455 (1955).
Baserga, A.: Les facteurs plaquettaires. Sang. 25, 742 (1954).
Baserga, A.,G. Ballerini: La résistance osmotique des plaquettes. Schweiz. med. Wschr. 1957, 1218.
Baumgartner, W.: Klinische Demonstrationen. Helv. med. Acta 23, 311 (1956).
Bell, W. N., and H. G. Alton: A brain extract as a substitute for platelet suspensions in the thromboplastin generation test. Nature (Lond.) 174, 880 (1954).
Bergsagel, D. E.: The role of calcium in the activation of Christmas factor. Brit. J.Haemat. 1, 199 (1955).
Bergsagel, D. E.: Viscous metamorphosis of blood platelets: Morphological platelet-changes induced by an intermediate product of blood thromboplastin. Brit. J. Haemat. 2, 130 (1956).
Bergsagel, D. E.,R. Biggs: The Christmas factor. Rev. Hémat. 10, 354 (1955).
Bergsagel, D. E., C. Hougie: Intermediate stages in the formation of blood thromboplastin. Brit.J. Haemat. 2, 113 (1956).
Bernhard, W., et R. Leplus: La methode des coupes ultrafines et son application à Tétude de l’ultrastructure des cellules sanguines. Schweiz. Med. Wschr. 1955, 897.
Bertrand, I., et D. Quivy: Evaluation au cours des dosages d’héparine de Tinter-actionhéparine-thrombokinase. Arch. int. Pharmacodyn. 79, 173 (1949).
Bessis, M.: Une méthode permettant Fisolement des differents éléments figurés du sang. Sang 14, 262 (1940).
Bessis, M.: Traité de Cytologie sanguine. Paris 1954.
Bessis, M.: The cytology of the blood-forming organs. New York 1956.
Bessis, M., J. Tabuis: Aspect dynamique des plaquettes sanguines. Rev. Hémat. 10, 753 (1955).
Bestetti, A., e P. F. Crosti: Ricerche cliniche sulle piastrine I., III. Atti Soc. lombarda Sci. med. biol. 10, 278, 284 (1955).
P. Lucchellie P. F. Crosti: Ricerche cliniche sulle piastrine II. Atti Soc. lombarda Sci. med. biol. 10, 281 (1955).
Bidwell, E., and R. Biggs: Development of platelet-like activity on storage of crude egg phospholipid. J. Physiol. (Lond.) 138, 37 P (1957).
Bierstedt, P.: Die Beteiligung der Thrombocyten an der Fibrinolyse, Abstr. 6. Congr. Soc. Europ. Hematol., Kopenhagen 1957.
Bigelow, F. S., and J. F. Desforges: The mobility of human platelets in a microelectrophoresis cell. Amer. J. Med. 14, 495 (1953).
Biggs, R.: Plasma Thromboplastin. Nature (Lond.) 170, 280 (1952).
Biggs, R., E. Bidwell: An attempt to identify a single phospholipid active in blood coagulation. Brit. J. Haemat. 3, 387 (1957).
Biggs, R., A. S. Douglas: The thromboplastin generation test. J. clin. Path. 6, 23 (1953).
Biggs, R.,R. G. Macfarlane: The formation of thromboplastin in human blood. J. Physiol. (Lond.) 119, 89 (1953)
Biggs, R.,R. G. Macfarlane: The action of thromboplastic substances. J. Physiol. (Lond.). 122, 538 (1953) (b).
Biggs, R.,R. G. Macfarlane: J. V. Dacie, W. R. Pitney, C. Merskeyand J. R. O’Brien: Christmas disease, a condition previously mistaken for haemophilia. Brit. med. J. 1952, 1378.
Biggs, R.,R. G. Macfarlane: and R. G. Macfarlane: Human blood coagulation and its disorders, 2. edit. Oxford 1957.
Bizzozero, J.: Über einen neuen Formbestandteil des Blutes und dessen Rolle bei der Thrombose und der Blutgerinnung. Virchows Arch. path. Anat. 90, 26l (1882).
Bloom, G.: The morphology of human blood platelets and the coagulation of human blood in vitro. Z. Zellforsch. 42, 365 (1955).
Bordet, J., et L. Delange: La coagulation du sang et la génèse de la thrombine. Ann. Inst. Pasteur 26, 657, 739 (1912).
Born, G. V. R.: The breakdown of adenosine triphosphate in blood platelets during clotting. J. Physiol. (Lond.) 133, 61 P (1956).
Born, G. V. R.: Evidence for the formation of a labile phospholipoprotein during the clotting of platelet-rich plasma. Nature (Lond.) 180, 546 (1957).
Born, G. V. R., O. Hornykiewicz: The proportionality between the uptakeof adrenaline byblood platelets and their content of adenosin triphosphate. J. Physiol. (Lond.) 136,30 P (1957).
Born, G. V. R., G. I. C. Ingramand R. S. Stacey: The proportionality between the amount of 5-hydroxytryptamine and adenosine triphosphate in blood platelets. J. Physiol (Lond.) 135, 63 P (1957).
Bounameaux, Y.: Recherches sur le mécanisme de l’adhésivité des plaquettes in vitro. Etudes sur Fatmosphère plasmatique. Arch. int. Physiol. 63, 531 (1955) (a).
Bounameaux, Y.: Thrombine et agglutination plaquettaire. Arch. int. Physiol. 63, 243 (1955)
Bounameaux, Y.:Recherches sur le mécanisme de la rétraction du caillot et de la métamorphose visqueuse des plaquettes. Experientia (Basel) 12, 355 (1956).
Bounameaux, Y.: Recherches sur le mécanisme de la formation de la thromboplastine sanguine. Acta haemat. (Basel) 17, 65 (1957)
Bounameaux, Y.:Dosage des facteurs de coagulation contenus dans Fatmosphère plasmatique des plaquettes humaines. Rev. franç. Ét. clin. biol. 2, 52 (1957) (b).
Bounameaux, Y.: Sur le mécanisme de la rétraction du caillot et de la métamorphose visqueuse des plaquettes. Rev. Hémat. 12, 16 (1957)
Bracco, Mand P. C. Curti: The vaso-constrictor factor of platelets. Experientia (Basel) Kongenitale Afibrinogenämie, 71 (1954).
Brambel, C. E., A. H. Corwinand V. A. Capone: Mechanism of action of heparin as an etiological basis for homeostasis (Hemorrhage and thrombosis). Amer. J med Sci. 230, 276 (1955).
Braunsteiner, H.: Über Morphologie, Physiologie und Pathologie der Thrombocyten Klin. Wschr. 1951, 835.
Braunsteiner, H., K. Fellingerand F. Pakesch: Structural changes in the platelets as observed by electron microscopy. Blood 9, 595 (1954).
F. Pakesch.,H. Vetter: Isolierung und Anreicherung funktionsrichtiger Leucozyten und Thrombozyten mittels Polyvinyl-Pyrrolidon. Acta haemat. (Basel) 8304 (1952).
Brinkhous, K. M.: A study of the clotting time in hemophilia: The delayed formation of thrombin. Amer. J. Med. Sci. 198, 509 (1939).
Brinkhous, K. M.: Clotting defect in hemophilia. Deficiency in a plasma factor required for platelet utilization. Proc. Soc. exp. Biol. (N. Y.) 66, 117 (1947).
Brinkhous, K. M.: H. P. Smith, E. D. Warnerand W. H. Seegers: Inhibition of blood clotting: an unidentified substance which acts in conjunction with heparin to prevent the conversion of prothrombin into thrombin. Amer. J. Physiol. 125, 683 (1939).
Brönnimann, R.: Kongenitale Afibrinogenämie: Mitteilung eines Falles mit multiplen Knochencysten und Bildung eines spezifischen Antikörpers (Antifibrinogen) nach Bluttransfusionen. Acta haemat. (Basel) 11, 41 (1954).
Budtz-Olsen, O. E.: Clot retraction. Oxford 1951.
Burstein, M., et M. Bessis: Etudes sur la physiologie des thrombocytes. Rev. Hémat 3, 69–91 (1948)
J. Loeb: L’inhibition de la thrombinoformation par Théparine. Rev. franç. Ét. clin. biol. 1, 752 (1956).
Cajano, A., e P. Polosa: Contributo allo studio della morfologia dei megacariociti e delle piastrine con la reazione di Feulgen. Haematologia 34, 1113 (1950).
Campbell, E. W., and W. J. Small: Metabolic functions of human platelets. J. clin. Invest. 35, 695 (1956).
Campbell, E. W., W. Dameshek: Metabolic activity of human blood platelets I. J. Lab. clin. Med. 47, 835 (1956).
Campbell, E. W., Lo Pilato: Comparative study of carbohydrate metabolism of human platelets. Proc. 6. Congr. Int. Soc. Hematol., Boston 1956, p. 523. New York 1958.
Campbell, E. W.,W. Dameshek: Glycolytic intermediates of human platelets. Their separation and identification. Proc. Soc. exp. Biol. (N. Y.) 94, 505 (1957).
Chambers, R., and B. W. Zweifach: Intercellular cement and capillary permeability. Physiol. Rev. 27, 436 (1947).
Chargaff, E., F. W. Bancroftand M. Stanley-Brown: Studies on the chemistry of blood coagulation: III. The chemical constituents of blood platelets and their role in blood clotting with remarks on the activation of clotting by lipids. J. biol. Chem. 116, 237 (1936).
A. Bendichand S. S. Cohen: The thromboplastic protein: structure, properties, disintegration. J. biol. Chem. 156, 161 (1944).
M. Ziffand S. S. Cohen: Studies on the chemistry of blood coagulation; X. The reaction between heparin and the thromboplastic factor. J. biol. Chem. 136, 257 (1940).
Chen, T. L., and L. Tsai: The mechanism of haemostasis in peripheral vessels. J. Physiol. (Lond.) 107, 280 (1948).
Chevalier, P., A. Fiehreret M. Samama: En marche de Thémophilie: La déficience en facteur Hageman. Sang 27, 950 (1956).
Chevillard, L.: Sur les phospho-monoestérases de la moelle du fémur, des ganglions lymphatiques, des leucocytes d’exsudats chez le cobaye, et des plaquettes sanguines chez le lapin. C. R. Soc. Biol. (Paris) 139, 249 (1945).
Chevillard, L.: Sur les pyrophosphatases de la moelle du fémur, des ganglions lymphatiques, des leucocytes d’exsudats chez le cobaye, et des plaquettes sanguines chez le lapin. C. R. Soc. Biol. (Paris) 140, 955 (1946).
Code, C. F.: Histamine in blood. Physiol. Rev. 32, 47 (1952).
Cohn, E. J.: Conference on: ,,The separation and the preservation of the formed elements and of the plasma proteins of human blood”, p. 24, Boston 1950.
Cole, J. W., H. Livingston, C. W. Loughryand W. D. Holden: Vasoconstrictor activity of blood platelets. Surgery 34, 482 (1953).
Conley, C. L., R. C. Hartmannand J. S. Lalley: The relationship of heparin activity to platelet concentration. Proc. Soc. exp. Biol. (N. Y.) 69, 284 (1948).
W. I. Morse: The clotting behaviour of human platelet-free plasma. Evidence for the existence of a plasma thromboplastin. J. clin. Invest. 28, 340 (1949).
Connor, W. E., and J. R. Carter: Influence of soybean phosphatide on blood coagulation and its use in the thromboplastin generation test. Proc. Soc. exp. Biol. (N. Y.) 97, 38 (1958).
Copley, A. L.: Embolization of platelet agglutination thrombi in the hamster pouch produced by heparin. Fed. Proc. 7, 22 (1948).
Copley, A. L.: Effect capillarogique de la fibrinolysine. Arch. int. Pharmacodyn. 99, 426 (1954).
Copley, A. L.: Neue Anschauungen über Haemorrhagie, Haemostase und Thrombose. Ärztl. Forsch. 11, 114 (1957).
Copley, A. L.: T. Baléa et Vo-Vinh-Hoa: Microméthode pour l’isolement des plaquettes sanguines chez Thomme et chez les petits mammifères. Rev. Hémat. 11, 324 (1956).
Copley, A. L.: , and D. F. Glaser: Studies on platelets. V. The effects of platelets on the surface tension of saline solutions and heparinized plasma. Blood (special issue) 1, 161 (1947).
Copley, A. L.: , and R. B. Houlihan: On the mechanism of platelet agglutination. Fed. Proc. 4, 173 (1945).
Copley, A. L.: Morphologic hematology. Blood (special issue) 1, 182 (1947).
Copley, A. L.: , and T. P. Robb: Studies on platelets. II. The effect of heparin on the platelet count in vitro. Amer. J. clin. Path. 12, 416 (1942).
Creveld, S. van : Functional pathology of the platelets. Acta haemat. (Basel) 12, 229 (1954).
Creveld, S. van : , and M. M. P. Paulssen: Significance of clotting factors in blood platelets, in normal and pathological conditions. Lancet 1951 II, 242. Isolation and properties of the third clotting factor in blood platelets. Lancet 1952 I, 23.
Csefkó, I., M. Gerendásand M. D. F. Unwardy: Kinase-heparin antagonism in vitro.Arch. biol. Hung. 18, 186 (1948).
Danielli, J. F.: Capillary permeability and oedema in the perfused frog. J. Physiol.98, 109 (1940).
J. T. Davies: Retractions at interfaces in relation to biological problems.Enzymol. 11, 35 (1951).
Datta, N., and J. Zajicek: Presence of pyrophosphatase in platelets. Acta haemat.12, 81 (1954).
Dausset, J.: Editorial. Vox Sang. (Basel) 1, 63 (1956)
Datta, N., Immuno-hématologie. Biologique et clinique. Paris 1956(b).
Datta, N., , and G. Malinvaud: Normal and pathological platelet agglutinins investigated by means of the shaking method. Confirmation of the presence of A and B antigens in platelets. Vox Sang. (Basel) 4, 204 (1954).
Delezenne, E.: Recherches sur la coagulation du sang chez les oiseaux. Arch. Physiol. 9, 333 (1897).
Desforges, J. F., and F. S. Bigelow: An action of thrombin on platelets in accelerating clotting. Blood 9, 153 (1954).
Deutsch, E.: Der Wirkungsmodus von „Hämostypticum 733 Schoch“. Arzneimittel-Forsch. 2, 470 (1952).
Datta, N., Differentiation of certain platelet factors in relation to blood coagulation. Rev. Hémat. 9, 483 (1954).
Datta, N., Blutgerinnungsfaktoren. Wien 1955
Datta, N., Über die Thrombokinasebildung und das Verhalten von Thrombozytenfaktor 1 bei Hypoproaccelerinämie (Parahämophilie). Wien. Z. inn. Med. 36, 355 (1955)
Datta, N., Thrombozytenfaktoren. Hämorrhagische Diathesen. Wien, S. 169. 1955(c).
Datta, N., Pathophysiologie der plasmatisch bedingten Coagulopathien. Hämorrhagische Diathesen, S. 83. Wien 1955(d).
Datta, N., Sh. A. Johnsonand W. H. Seegers: Differentiation of certain platelet factors related to blood coagulation. Circulat. Res. 3, 110 (1955).
Datta, N., , u. W. Schaden: Zur Reinigung und Charakterisierung des VII. Blutgerinnungsfaktors. Biochem. Z. 324, 266 (1953).
Datta, N., E. Wawersichand G. Franke: The relation of different platelet factors to brain thromboplastin. Proc. 6. Congr. Int. Soc. Hematol., Boston 1956, p. 477. New York 1958.
Datta, N., Über das Vorkommen eines Antiheparinfaktors in Thrombozyten und Geweben. I. Mitt.: Antiheparinaktivität der Thrombozyten. Thromb. Diath. haem. 1, 397
Mitt.: Antiheparinaktivität von Hirnextrakten. Thromb. Diath. haem. 1, 406 (1957)
Dick, F. W., D. P. Jacksonand C. L. Conley: Surface as a quantitative factor in pro- thrombin utilization. J. clin. Invest. 33, 1423 (1954).
Discombe, G.: Phase contrast microscopy. Acta haemat. (Basel) 3, 151 (1950).
Djerassi, I., E. Kleinand V. Lauris: Human platelet material and thrombin activity. Proc. 6. Congr. Int. Soc.Hematol., Boston 1956, p. 55. New York 1958.
Donné, A.: De Forigine des globules du sang, de leur modes de formation, de leur fin. C. R. Acad. Sci. (Paris) 14, 366 (1842).
Douglas, A. S.: Antihaemophilic globulin consumption during blood coagulation.Blood 11, 423 (1956)
Douglas, A. S.: Factor V consumption during blood coagulation. Brit. J. Haemat. 2, 153 (1956) (b).
Douglas, A. S.: The action of heparin in the prevention of prothrombin-conversion. J. clin. Invest. 35, 533 (1956) (c).
Dreskin, O. H.: Two stage prothrombin analysis using hemolyzed whole blood thrombo- plastin. Clin. Res. Proc. 3, 32(1955).
Duckert, F., P. Flückiger, H. Isenschmid, M. Matter, J. Vogel-Mengand F. KollerA modification of the thromboplastin generation test. Actahaemat. (Basel) 12197(1954).
Duguid, J. B.: The arterial lining. Lancet 1952 II, 207.
Eberth, J. C., u. C. Schimmelbusch: Die Blutplättchen und die Blutgerinnung. Vir- chows Arch. path. Anat. /101, 201 (1885).
Biochem. Z Experimentelle Untersuchungen über Thrombose. Virchows Arch. path. Anat. 10339 (1886).
Eiseman, G., and M. Stefanini: Thromboplastic activity of leukemic white cells. Proc. Soc. exp. Biol. (N. Y.) 86, 763 (1954).
Ellicott, C. E., and C. L. Conley: Retraction of clots formed from purified prothrombin. Bull. Johns Hopk. Hosp. 88, 321 (1952).
Emerson, C. P.: A practical procedure for the individual separation and removal of erythrocytes, leukocytes and platelets from human blood. Proceedings of the Conference on the Preservation of the formed elements and of the Proteins of the Blood, Boston 1949.
Endres, G., u. L. Herget: Mineralzusammensetzung der Blutplättchen und weißen Blutkörperchen. Z. Biol. 88, 451 (1929).
F. Kubowitz: Stoffwechsel der Blutplättchen. Biochem. Z. 191, 395 (1927).
Epstein, E., u. A. Goedel: Haemorrhagische Thrombozythämie bei vasculärer Schrumpfmilz. Virchows Arch. path. Anat. 292, 233 (1934).
J. Kretz: Über einen Fall von hochgradiger Thrombozytenvermehrung. Klin. Wschr. 1930, 1177.
A. J. Quick: Effect of injecting platelet extract intravenously. Proc. Soc. exp. Biol. (N. Y.) 83, 453 (1953).
Erickson, B. N., H. H. Williams, I. Avrinand P. Lee: The lipid distribution in human platelets in health and diseases. J. clin. Invest. 18, 81 (1939).
Erkelens, A. D.: De plaats der thrombocyten in het stollingsproces. Rotterdam 1956.
Fanger, H., L. J. Cellajr. and H. Litchman: Thrombocythemia. Report of three cases and review of the literature. New Engl. J. Med. 250, 456 (1954).
Feissly, R.: Recherches sur la nature et Forigine de la thrombokinase plasmatique. Helv. med. Acta 12, 215 (1945).
Feissly, R.: Comportement du plasma et des éléments figurés du sang en présence de parois mouillables et non mouillables. Compt. rend. 3. Congr. Soc. Europ. Hématol., S. 798. Rome 1951.
Feissly, R.: Actes 2. Symp. Fondation V. Baldacci, Pisa 1959
Feissly, R.: A. Gautieret I. Marcovici: Nouveau procédé d’examen des thrombocytes au microscope électronique. Rev. Hémat. 12, 397 (1957).
Feldman, D., and D. Kirman: Effect of ultrasonics on thromboplastinase-labile components and toxicity of injected thromboplastin. Proc. Soc. exp. Biol. (N. Y.) 94, 695 (1957).
Fenichel, R. L.: Bovine platelets, serotonin and the retraction of human plasma clots. Clin. Chem. 2, 281 (1956).
Feissly, R.: W. H. Seegers: Bovine platelets, serotonin and the retraction of bovine plasma clots. Amer. J. Physiol. 181, 19 (1955).
Feissly, R.: Studies on human clot retraction. J. appl. Physiol. 10, 71 (1957).
Ferguson, J. H.: The present status of the platelets in coagulation. Trans. 2. Conf. of Josiah Macy Fondation on blood clotting allied problems, p. 210, New York 1949
B. N. Erickson: The coagulant action of crystalline trypsin, cephalin and lung extracts. Amer. J. Physiol. 126, 661 (1939).
Fishman, W. H., B. Springer and R. Brunetti: Study of human blood ß-glucuronidase.J. biol. Chem. 173, 449 (1948).
Fonio, A.: Neuere Untersuchungen über Blutgerinnung. Schweiz. Med. Wschr. 1923, 36.
Feissly, R.: La fonction retractile des thrombocytes à Fétat normal et dans les états pathologiques de Fhomme. Bull. Schweiz. Akad. med. Wiss. 4, 470 (1948).
Feissly, R.: Eine neue Methode zur Kontrolle der Wirkung von Antikoagulantien in vivo und in vitro. Schweiz. Med. Wschr. 1950, 1095.
Feissly, R.: Über das funktioneile Verhalten der isolierten Strukturelemente der Thrombocyten, des Hyalomers und des Granulomers. Acta haemat. (Basel) 6, 207 (1951).
Feissly, R.: Über die Wirkung des Hyalomers der Thrombocyten auf den Retraktionsvorgang. Acta haemat. (Basel) 8, 363 (1952).
Feissly, R.: Über die Morphologie und den Gestaltswandel der hämophilen Thrombozyten. Schweiz. med. Wschr. 1956, 1439.
Feissly, R.: . J. Schwendener: Die Thrombocyten des menschlichen Blutes. Bern 1942.
Freeman, G.: Method for obtaining large yields of human platelets as a by-product of blood collection. Science 114, 527 (1951).
Frick, P. G., and P. S. Hagen: Severe coagulation defect without hemorrhagic symptoms caused by a deficiency of the 5th plasma thromboplastin precursor. J. Lab. clin. Med. 47, 592 (1956).
Fujita, A.: Über den Stoffwechsel der weißen Blutzellen. Klin. Wschr. 1928, 897.
Feissly, R.: E. Klein: Differentiation of antiheparin and thromboplastin generating factors in human platelets. Proc. Soc. exp. Biol. (N. Y.) 96, 823 (1957).
Glanzmann, E.: Hereditäre hämorrhagische Thrombasthenie. Jb. Kinderheilk. 88, 113 (1918).
Goldstein, R., and B. Alexander: Coagulation factors concerned with thromboplastin generation. Fed. Proc. 14, 219 (1955).
Feissly, R.: and E. B. Zonderman: The role of proconvertin in citrate or thromboplastin conversion of prothrombin. Proc. 6. Congr. Int. Soc. Hematol., Boston 1956, p. 598. New York 1958.
Gollub, S.: Action of thromboplastinase on human blood thromboplastin. J. appl. Physiol. 7, 409 (1955).
Goucher, Ch. R., and W. Kocholaty: Reflectance spectra and some respiratory reactions of bovine, equine and human erythrocytes. Amer. J. Physiol. 188, 415 (1957).
Graham, H. T., O. H. Lowry, F. Wheelwright, M. A. Lenz and H. H. Parish: Distribution of histamine among leucocytes and platelets. Blood 10, 467 (1955).
Greene, R. W.: Effects of pH on platelets and identification of ribonucleoprotein from platelets. Proc. Soc. exp. Biol. (N. Y.) 87, 412 (1954).
Feissly, R.: Effects of thrombin and platelet concentrations and of clot retraction on fibrin strand width. J. clin. Invest. 34, 417 (1955).
Gross, R., u. G. Schwick: Über die Gerinnungsaktivität und intravenöse Anwendung lyophil getrockneter menschlicher Thrombozyten. Klin. Wschr. 1957, 814.
Gurevitch, J., and D. Nelken: ABo groups in blood platelets. Nature (Lond.) 173, 356 (1954).
Guttmann, W.: Die Kernsubstanzen der Blutplättchen. Z. ges. inn. Med. 2, 362 (1947).
Halick, P., and W. H. Seegers: Antigenic properties of purified bovine prothrombin.Amer. J. Physiol. 187, 103 (1956).
Hardisty, R. M., G. I. C. Ingramand R. S. Stacey: Reserpine and human platelet-5-hydroxytryptamine. Experientia (Basel) 12, 424 (1956).
Feissly, R.: R. S. Stacey: 5-hydroxytryptamine in normal human platelets. J. Physiol. (Lond.) 130, 711 (1955).
Hartert, H.: Thrombelastographische Untersuchungen zur Thrombusbildung. Klin. Wschr. 1949, 789.
Hartert, H.: Thrombelastographische Untersuchungen zur Retraktion. Klin. Wschr. 1950, 78.
Feissly, R.: Ein Retraktions-Cofaktor im Serum. Klin. Wschr. 1954, 139
Feissly, R.: H. G. Laschu. I. Pfisterer: Charakterisierung und Funktion eines Retraktions-Cofaktors. Thromb. Diath. haem. 1, 445 (1957).
Hartmann, R. C., C. L. Conleyand J. S. Lalley: Studies on the initiation of blood coagulation. I. The relationship of platelets to the clot promoting effect of glass surfaces. Bull. Johns Hopk. Hosp. 85, 231 (1949).
Haurowitz, F., u. J. Sladek: Über die chemische Zusammensetzung der Blutplättchen.Hoppe-Seylers Z. physiol. Chem. 173, 233 (1928).
Haverback, B. J., T. F. Dutcher, P. A. Shore, E. G. Tomich, L. L. Terryand B. B.Brodie: Serotonin changes in platelets and brain induced by small daily doses of reserpine. New Engl. J. Med. 256, 343 (1957).
Hawn, C. van Zandtand K. R. Porter: The fine structure of clots formed from purified bovine fibrinogen and thrombin: A study with the electron microscope. J. exp. Med. 86, 284 (1947).
Hayem, G.: Recherches sur l’évolution des hématies dans le sang de Thomme et des vertébrés. Arch. Physiol. norm. 5, 692 (1878).
Feissly, R.: Sur le mécanisme de l’arrêt des hémorrhagies. C. R. Acad. Sci. (Paris) 95, 18 (1882).
Feissly, R.: Du sang et ses altérations anatomiques. Paris 1889.
Hecht, E.: Untersuchungen über die chemische Natur der Gerinnungsaktivatoren. Sang 21, 486 (1950).
Feissly, R.: Wechselwirkungen zwischen fördernden und hemmenden Substanzen der Blutgerinnung. Experientia (Basel) 10, 428 (1954).
Feissly, R.: Over de thrombocytenfactor 3 (,,T 3”). Ned. T. Geneesk. 101, 429 (1957)
Feissly, R.: Studien über den lipoiden Aktivator der Blutgerinnung. Thromb. Diath. haem. 1, 380 (1957) (b).
Feissly, R.: R. H. Landaburuand W. H. Seegers: Sphingosine as inhibitor of prothombin activation with thromboplastin or with threone. Amer. J. Physiol. 189, 203 (1957).
Feissly, R.: . D. Shapiro: Versuche zur chemischen Identifikation und Synthese von Gerinnungsfaktoren. Thromb. Diath. haem. 1, 359 (1957)
Feissly, R.: Sphingosine as an inhibitor of blood clotting. Science 125, 1041 (1957)
Hirose, R. S.: The second phase of thrombin action: Fibrin resolution. Amer. J. Physiol. 107, 693 (1934).
Hittmair, A.: Das Blutplättchen im Schrifttum der letzten 10 Jahre. Folia haemat. (1pz.) 59, 50–92 (1938).
Hitzenberger, G., u. E. Keibl: Cytochemische Untersuchungen zur Frage der Thrombozytenabstammung. Wien. klin. Wschr. 1954, 669.
Hjort, P., S. I. Rapaportand P. A. Owren: Platelet accelerator identical to pro- accelerin and adsorbed from plasma. Scand. J. clin? Lab. Invest. 7, 97 (1955)
Feissly, R.: Evidence that platelet accelerator (platelet factor 1) is adsorbed plasma accelerin. Blood 10, 1139 (1955) (b).
Holst, E. J.: Hemorrhagic thrombocythemia. Acta med. scand. 130, 507 (1948).
Z. ges. exp. Med. 73, 434 (1930). Hougie, C., E. M. Barrow and J. B. Graham: Stuart clotting defect: I. Segregation of an hereditary hemorrhagic state from the heterogenous group, heretofore called: „stable factor“ (SPCA, Proconvertin, F. VII)-deficiency. J. clin. Invest. 36, 485 (1957).
Feissly, R.: Stuart factor: A hitherto unrecognized blood coagulation factor. Proc.Congr. Int. Soc. Blood Transfusion, Boston 1956, p. 336. Basel u. New York 1958.
Houlihan, R. B., and A. L. Copley: The adhesion of rabbit platelets to bacteria. J. Bact. 52, 439 (1946).
Howell, W. H.: Structure of the fibrin gel and theories of gel formation. Amer. J. Phy- siol. 40, 526 (1916).
Howell, W. H.: and E. Holt: Two new factors in blood coagulation: Heparin and pro-antithrombin.Amer. J. Physiol. 47, 328 (1918).
Hugues, J.: Actes 2. Symp. Fondation V. Baldacci, Pisa 1959.
Hutter, R. V. P.: Electron microscopic observations on platelets from human blood.Amer. J. Clin. Path. 28, 447 (1957).
Iglauer, K., u. S. Weber: Die Katalasewirkung der Thrombozyten. Biochem. Z. 234, 489 (1931).
Isenschmid, H.: Über die Wirkung des Thrombins im Thrombokinasebildungstest. Acta haemat. (Basel) 13, 177 (1955).
Iyengàr, N. K.: Trypsin-kinase in blood. Proc. Ind. Acad. Sci. B 15, 106 (1942).
Jaques, L. B., E. Fidlar, E. T. Feldstedand A. S. Macdonald: Silicones and blood coagulation. Canad. med. Ass. J. 55, 26 (1946).
Johnson, J. F., and W. H. Seegers: Techniques in blood coagulation used at Wayne University, Detroit 1953.
Johnson, J. F., and W. H. Seegers: Activation of purified prothrombin with hemophilic plasma. Amer. J. clin. Path. 23, 875 (1953).
C. L. Schneider: The existence of antifibrinolysin activity in platelets. Science 117, 229 (1953).
W. M. Smathersand C. L. Schneider: Platelets and their plasma cofactor activity in the activation of purified prothrombin. Amer. J. Physiol. 170, 631 (1952).
Jürgens, R.: Die Blutplättchen und ihre Bedeutung für Blutungsneigung und Thrombusbildung. Dtsch. med. Wschr. 1952, 1265.
Jürgens, R.: Pharmakologische Beeinflussung der Blutgerinnung. Naunyn-Schmiedeberg’s Arch. exp. Path. Pharmak. 222, 107 (1954)
Jürgens, R.: Funktion der Thrombocyten bei Blutung und Thrombose. Wien. klin. Wschr. 1954 (b), 850.
Jürgens, R.: . E. Deutsch(Herausgeber): Hämorrhagische Diathesen. Int. Symp. Wien 1955.
Kabat, E. A.: Blood group substances. Their chemistry and immunochemistry. New York 1956.
Kaznelson, P.: Thrombolytische Purpura. Z. klin. Med. 87, 133 (1919).
Kissmeyer-Nielsen, F.: Demonstration of platelet antibodies by hemagglutination of tannin coated erythrocytes. Vox Sang. (Basel) 3, 123 (1953).
Klein, E., P. Arnold, R. T. Earland E. Wake: A practical method for the aseptic preparation of human platelet concentrates without loss of other blood elements.New Engl. J. Med. 254, 1132 (1956).
Klein, E., P. Arnold, R. T. Earland E. Wake: Sim,ple methods for the aseptic separation of blood components. Proc.6. Congr. Int. Soc. Blood Transfusion, Boston 1956, p. 382. Basel u. New York 1958.
I. Djerassi and S. Farber: Hemostasis following the administration of lyophilized platelet material in secondary thrombocytopenia. Proc. 6. Congr. Int. Soc. Hematol., Boston 1956, p. 525. New York 1958.
S. Farber, G. Freemanand R. Fiorentino: The effects of varying concentrations of human platelets and their stored derivatives on the recalcification time of plasma. Blood 11, 910 (1956).
R. Fiorentino: Effects of varying concentrations of platelets and their lyophilized derivatives on generation of thromboplastin. Proc. Soc. exp. Biol. (N. Y.) 94, 357 (1957).
Toch, S. Farber, G. Freemanand R. Fiorentino: Hemostasis in thrombocytopenic bleeding following infusion of stored frozen platelets. Blood 11, 693 (1956).
Köppel, G.: Elektronenoptische Untersuchungen zur Funktionsmorphologie der Thrombozyten und zum Gerinnungsablauf im normalen menschlichen Nativblut. Z. Zellforsch. 47, 401 (1958).
Koller, F.: Die Physiologie der Blutgerinnung. Ihre Bedeutung für die Klinik. Naunyn-Schmiedeberg’s Arch. exp. Path. Pharmak. 222, 89 (1954).
Koller, F.: Le facteur X. Rev. Hémat. 10, 362 (1955).
Koppel, J. L., and J. H. Olwin: Dehydrogenase activities of human platelets. Fed. Proc. 13, 244 (1954).
Kotilainen, M. L., and A. Wilska: Observations on living thrombocytes under the anoptral contrast microscope. Ann. Med. exp. Fenn. 33, 76 (1955).
Kwaan, H. C., R. Loand A. J. S. McFadzean: On the lysis of thrombi experimentally produced within veins. Brit. J. Haemat. 4, 51 (1958).
Laki, K.: The autocatalytic formation of thrombin and the clotting defect of hemophilic blood. Stud. Inst. Med. Chem. Univ. Szeged 3, 5 (1943).
L. Lorand: On the stability of fibrin clots. Science 108, 280 (1948).
Larrieu, M. J., H. Caen, P. Grenet, J. Caylaet J. Bernard: Hypoaccélérinémie congénitale (Parahémophilie). Sang 27, 117 (1956).
Lasch, H. G., I. Pfistereru. K. Schimpf: Über das Verhalten des Gerinnungsfaktors.VII im Kreislauf der Katze. Acta haemat. (Basel) 17, 280 (1957).
L. Roka: Zur Prothrombinbildung in der Leber. Hoppe-Seylers Z. physiol. Chem. `294, 30 (1953).
Leathes, J. B., and J. Mellanby: Thrombokinase from brain. J. Physiol. (Lond.) 96, 38 P (1939).
Lee, Ch.-Y., S. A. Johnson and W. H. Seegers: Clotting of blood with Russel’s viper venom. J. Mich. med. Soc. 54, 801 (1955).
S. A. Johnsonand W. H. Seegers: Platelet cothromboplastin: A platelet factor related to the blood clotting mechanism. Thromb. Diath. haem. 1, 16 (1957).
Leeksma, C. H. W., and J. A. Cohen: Determination of life-span of human blood platelets using labelled diisopropyl-fluorophosphate. Nature (Lond.) 175, 552 (1955).
Lenggenhager, K.: Die Lösung des hämophilen Blutungs- und Gerinnungsrätsels. Mitt. Grenzgeb. Med. Chir. 44, 425 (1936).
Lenggenhager, K.: Einige Klärungen in der Blutgerinnungsfrage. Schweiz. med. Wschr. 1946, 410.
Lenggenhager, K.: Weitere Fortschritte in der Blutgerinnungslehre. Leipzig 1949.
Le Sourd, L., et P. Pagniez: Du rôle des hématoblastes dans la rétraction du caillot. C. R. Soc. Biol. (Paris) 61, 109 (1906).
Le Sourd, L., Nouvelles recherches sur le rôle des plaquettes dans la rétraction du caillot sanguin. C. R. Soc. Biol. (Paris) 65, 400 (1908).
Le Sourd, L., Recherches sur le rôle des plaquettes sanguines ou hématoblastes dans la coagulation du sang. J.Physiol. Path. gén. 15, 812 (1913).
Leupold, R.: Zur thromboplastischen Wirkung von Erythrozyten. Schweiz. med.Wschr. 1955, 911.
Lewis, J. A., and J. H. Ferguson: Hypoproaccelerinemia. Blood 10, 351 (1955).
Loeb, L.: Über die Blutgerinnung bei Wirbellosen. Biochem. Z. 24, 478 (1910).
Loeber, J.: Zur Physiologie der Blutplättchen. Pflügers Arch. ges. Physiol. 140 (1911).
Loewy, A. G., and J. T. Edsall: Studies on the formation of urea-insoluble fibrin.J. biol. Chem. 211, 829 (1954).
Lorand, L.: Interaction of thrombin and fibrinogen. Physiol. Rev. 34, 742 (1954).
Lozner, E. L., and F. H. L. Taylor: The effect of foreign surfaces on blood coagulation. J. clin. Invest. 21, 241 (1942).
Lüscher, E. F.: Untersuchungen über eine die Blutgerinnung fördernde Substanz aus dem Harne Hämophiler. Diss. Universität Bern 1946.
Lüscher, E. F.: Fibrinretraktion und Thrombozytenproteine. Helv. physiol. pharmacol. Acta 11, C64 (1953).
Lüscher, E. F.: Thrombozytenproteine und Gefäßpermeabilität, ,,Hämorrhagische Diathesen”, S. 117. Wien 1955.
Lüscher, E. F.: Die physiologische Bedeutung der Thrombozyten. Schweiz. med. Wschr. 1956 345.
Lüscher, E. F.: Viscous metamorphosis and clot retraction. Vox Sang. (Basel) 1, 133 (1956
Lüscher, E. F.: Glukose als Cofaktor bei der Retraktion des Blutgerinnsels. Experientia (Basel) 12, 294 (1956) (c).
Lüscher, E. F.: Actes 2. Symp. Fondation V. Baldacci, Lissabon 1957 (a) (im Druck).
Lüscher, E. F.: Ein fibrinstabilisierender Faktor aus Thrombocyten. Schweiz. med. Wschr. 1957 (b), 1220.
Lüscher, E. F.: Unveröffentlichte Ergebnisse 1958.
Lyttleton, J. W.: Biophysical studies on thrombin and antithrombin and the kinetics of their reaction. Thesis, Univ. of London 1950.
Lyttleton, J. W.: Vitamin K and the estimation of prothombin. Proc. roy. Soc. Med. 35, 410 (1942).
Lyttleton, J. W.: Blood coagulation. Physiol. Rev. 36, 479 (1956).
Magalini, S. L, and M. Stefanini: Clot- retraction promoting factor (retractin) in platelets and tissues. Science 123, 796 (1956) (a).
Magalini, S. L, and M. Stefanini: Failure of serotonin in inducing retraction of a platelet poor plasma clot. Proc. Soc. exp. Biol. (N. Y.) 90, 615 (1956) (b).
Magalini, S. L, and M. Stefanini: Studies on platelets XVI: Glutamic oxaloacetic transaminase - activity on human platelets. Proc. Soc. exp. Biol. (N. Y.) 91, 404 (1956) (c).
Magalini, S. L, and M. Stefanini: A platelet factor responsible for clot retraction. Lancet 1956 I(d), 246.
Mann, F. D.: A preliminary reaction of coagulation factors found in plasma and serum. Circulat. Res. 5, 481 (1957).
M. Hurn and N. Barker : Platelets and the coagulation defect caused by dicumarol. Amer. J. clin. Path. 21, 814 (1951).
T. B. Magath: Observations on the conversion of prothrombin to thrombin. Proc. Soc. exp. Biol. (N. Y.) 66, 33 (1947).
Marbet, R., u. A. Winterstein: Synonyma der Gerinnungsfaktoren. 1. Int. Tagg über Thrombose und Embolie, S. 53, Basel 1955 (a).
Marbet, R., Der Heparintoleranztest. Ärztl. Forsch. 10, 460 (1955) (b).
Margolis, J.: Plasma pain-producing substances and blood clotting. Nature (Lond.) 180, 1464 (1957).
Marx, R.: Verh. ber. 58. Tagg Dtsch. Ges. Inn. Med. Dtsch. med. Wschr. 1952, 925.
Marx, R.: Verh. 3. Symp. Dtsch. Arbeitsgemeinschaft für Blutgerinnungsforsch., Thromb. Diath. haem. 2, 192 (1958).
Marx, R., S. Derlath : Über eine Methode zur vergleichend quantitativen Bestimmung der Thrombozytenadhäsivität an blutfremden Oberflächen unter gleichzeitiger Erfassung der relativen Blutviskosität. Blut 3, 247 (1957).
Maspes, V., T. Verrastro, E. Coelho e M. Jamra: Agglutinas plaqueteras I. Agglutination inespecifica por un factor de la coagulation contenido en el suero normale (F. VII). Sangre 1, 156 (1956).
Matthes, M., u. K. Sickinger: Herstellung von Thrombozytenkonzentraten für Transfusionszwecke bei Verwendung verschiedener Dextranfraktionen. Acta haemat. (Basel) 15, 278 (1956).
Maupin, B.: Les plaquettes sanguines de Fhomme. Paris 1954.
Maupin, B., et R. Chary: Présentation d’une nouvelle méthode de séparation des leucocytes et des plaquettes sanguines. Sang 23, 336 (1952).
McClaughry, R. L, and W. H. Seegers: Prothrombin, thromboplastìn, ac.-globulin and platelet accelerator. Quantitative interrelationships. Blood 5, 503 (1950).
Mertz, E. T., W. H. Seegers and H. P. Smith: Inactivation of prothrombin by purified thrombin solution. Proc. Soc. exp. Biol. (N. Y.) 41, 657 (1939).
Miller, K. D.: Structural studies of the prothrombin-thrombin system. Vox Sang. (Basel) 3, 63 (1958).
Miller, K. D.: and H. van Vunakis: The effect of diisopropylfluoro-phosphate on the proteinase and esterase activities of thrombin and on prothrombin and its activators. J. biol. Chem. 223, 227 (1956).
Milstone, J. H.: The chain reaction of the blood clotting mechanism in relation to the theory of hemostasis and thrombosis. Blood 4, 1920 (1949).
Milstone, J. H.: Effect of blood thrombokinase as influenced by soybean trypsin inhibitor, ultracentrifugation and accessory factors. J. gen. Physiol. 38, 757 (1955).
Minor, A. H., and L. Burnett: A method for separating and concentrating platelets from normal human blood. Blood 7, 693 (1952).
Mocchi, N.: La morfologia delle piastrine nell’uomo normale e dopo trattamento con ormone maschile. Haematologica 36, 605 (1952).
Monkhouše, F. C., and D. W. Clarke: Purification of antithrombin and heparin cofactor. Canad. J. Biochem. 35, 373 (1957).
E. S. France and W. H. Seegers : Studies on the antithrombin and heparin cofactor activities of a fraction absorbed from plasma by aluminum hydroxyde. Circulat. Res. 3, 397 (1955).
Moolten, S. E., and L. Vroman: The adhesiveness of blood platelets in thromboembolism and hemorrhagic disorders. I. Measurement of platelet adhesiveness by the glass wool filter. Amer. J. clin. Path. 19, 701 (1949).
Morawitz, P.: Die Chemie der Blutgerinnung. Ergebn. Physiol. 4, 307 (1905).
Morgan, W. T. J.: The human AB 0 blood group substances. Experientia (Basel) 3, 257 (1947).
Morita, H.: Studies on amino acids in platelets. Acta haemat. jap. 16, 76 (1953).
Morita, H.: Studies on blood platelets. Proc. 6. Congr. Int. Soc. Hematol., Boston 1956, p. 561. New York 1958.
Morrison, P., and W. H. Rothman: Agglutination of blood cells in limulus polyphemus. Proc. Soc. exp. Biol. (N. Y.) 94, 21 (1957).
Mortensen, O.: Thrombocythaemia haemorrhagica. Acta med. scand. 129, 547 (1948).
Moulinier, J., and F. Mesnier: Use of lipoid platelet extracts in the agglutination reaction of sensitized particles. Vox Sang. (Amsterdam) 4, 199 (1954).
Moureau, P., et A. Andre: Mise en évidence des antigènes de type A et B dans les pla- quettes. C. R. Soc. Biol. (Paris) 148, 174 (1954) (a).
Moureau, P., Blood groups of human blood platelets. Nature (Lond.) 174, 88 (1954) (b).
Murray, M., Sh. A. Johnson and W. H. Seegers: Activation of purified prothrombin in association with synthetic organic compounds and platelet extract. Science 119, 293 (1952).
Murray, M., Relationship of certain antihistamine drugs to the activation of purified prothrombin. Amer. J. Physiol. 178, 10 (1954).
Nikolaeva, N. I.: Thrornbocytes as one of the sources of blood enzymes. Byull. Eksp. Biol. Med. 22, 24 (1946).
Nour-Eldin, F., and J. F. Wilkinson: Two stages in the formation of active plasma thromboplastin. Nature (Lond.) 178, 856 (1956) (a).
Nour-Eldin, F., The separation of human and bovine plasma thromboplastin with ether and a study of its properties. J. Physiol. (Lond.) 132, 164 (1956) (b).
O’Brien, J. R.: The similarity of action of phosphatidyl ethanol-amine and platelets in blood coagulation. J. clin. Path. 9, 47 (1956).
O’Brien, J. R.: The effect of some fatty acids and phospholipids on blood coagulation. Brit. J. exp. Path. 38, 529 (1957).
Odell, T. T., and B. Anderson: Isolation of a sulfated mucopolysaccharide from blood platelets of rats. Proc. Soc. exp. Biol. (N. Y.) 94, 151 (1957).
Odell, T. T., and A. C. Upton : Distribution of calcium in platelets and bone marrow of rats. Acta haemat. (Basel) 14, 291 (1955).
Oeri, J., M. Matter, H. Isenschmid, C. Hauser u. F. Koller: Angeborener Mangel an Faktor V (Parahämophilie) verbunden mit echter Hämophilie A bei zwei Brüdern.Mod. Probl. Pädiatr. 1, 575 (1954).
Olef, J.: Determination of platelet volume. J. Lab. clin. Med. 23, 166 (1937).
Øllgaard, E.: Clot retraction as a quantitative test of the function and agglutinability of the blood platelets. Acta haemat. (Basel) 6, 220 (1951).
Onaka, M.: Über Oxydationen im Blut. Hoppe-Seylers Z. physiol. Chem. 71 193 (1911).
Opitz, H., u. W. Schober: Klinische und experimentelle Studien über die Bedeutung der Blutplättchen für die Retraktilität des Blutkuchens. Jb. Kinderheilk. 53, 189 (1923).
Owren, P. A.: The coagulation of blood; Investigations on an new clotting factor. Acta med. scand. Suppl. 194 (1947).
Owren, P. A.: The fifth coagulation factor — preparation and properties. Biochem. J. 43, 136 (1948).
Owren, P. A.: The present state of the converting and accelerator factors in prothrombin conversion.Thrombose und Embolie. 1. Int. Tagg, Basel 1954, S. 65. Basel 1955.
Owren, P. A.: S. I. Rapaport, P. Hjort and K. Aas: The biochemistry of thromboplastin, its formation and action. Sang 25, 752 (1954).
Oye, E. L. van : Note sur les acides nucléiques des plaquettes sanguines. Haematologica 31, 689 (1948).
Page, I. H.: Serotonin (5-hydroxytryptamine). Physiol. Rev. 34, 563 (1954).
Page, I. H.:Serotonin (5-hydroxytryptamine); the last four years. Physiol. Rev. 38, 277 (1958).
Parrot, J. L., et M. Gabe: Sur la répartition de Fhistamine dans les éléments constitutifs du sang humain. C. R. Soc. Biol. (Paris) 139, 965 (1945).
Pedrazzini, A., u. E. Salvidio: Die Fermente der menschlichen Thrombozyten und ihre wahrscheinliche Bedeutung im Mechanismus der Blutstillung (Hämostase). Schweiz. med. Wschr. 1956, 1097
Penner, J. A., F. Duckert, Sh. A. Johnson and W. H. Seegers: Conversion of prothrombin to autoprothrombin II. Canad. J. Biochem. 34, 1199 (1956).
Perry, S., and Ch. G. Craddock jr.: Platelet adsorptive properties and platelet extracts in thromboplastin generation. Blood 13, 177 (1,958).
Peterson, E. A., and H. A. Sober: Chromatography of proteins. I. Cellulose ionexchange adsorbents. J. Amer. chem. Soc. 78, 751 (1956).
Pettavel, J., et B. Vuilleret: Les variations de la coagulabilité appréciées in vitro par le test à Fhéparine de Marbet et Winterstein en fonction des valeurs de Quick et de differentes concentrations plaquettaires. Helv. chir. Acta 24, 39 (1957).
Pinniger, J. L., and F. I. G. Prunty: Some observations on the blood clotting mechanism: The role of fibrinogen and platelets with reference to a case of congenital afibrinogenaemia. Brit. J. exp. Path. 27, 200 (1946).
Quick, A. J.: On the action of heparin and its relation to thromboplastin. Amer. J. Physiol. 115, 317 (1936).
Page, I. H.:The normal antithrombin of the blood and its relation to heparin. Amer. J. Physiol. 123, 712 (1938).
Page, I. H.:Studies on the enigma of the hemostatic dysfunction of hemophilia. Amer. J. med. Sci. 214, 272 (1947).
Page, I. H.:The physiology and pathology of haemostasis. London u. Philadelphia 1951.
Page, I. H.:Hemorrhagic diseases. Philadelphia 1957.
Page, I. H.:and E. Epstein: Thromboplastic activity in human blood. J, appl. Physiol. 4, 840 (1952).
Page, I. H.:J. G. Georgatsos and C. V. Hussey: The clotting activity of human erythrocytes. Theoretical and clinical implications. Amer. J. med. Sci. 228, 207 (1954).
Page, I. H.:and C. V. Hussey : Initiation of the clotting of blood. Proc. Soc. exp. Biol. (N. Y.) 80, 40 (1952).
Ranvier, M.: Du mode de formation de la fibrine dans le sang extrait des vaisseaux. C. R. Soc. Biol. (Paris) 5, 46 (1873).
Rapaport, S. L, K. Aas and P. A. Owren: The effect of glass upon the activity of the various plasma clotting factors. J. clin. Invest. 34, 9 (1955).
Rátnoff, O. D.: A familial trait characterized by deficiency of a clot promoting fraction of plasma. J. Lab. clin. Med. 44, 915 (1954).
A. Margolius jr.: The hereditary nature of Hageman trait. Proc. 6. Congr. Int.Soc. Hematol., Boston 1956, p. 513. New York 1958.
J. M. Rosenblum: Role of Hageman-factor in the initiation of clotting by glass.J. Lab. clin. Med. 50, 941 (1957).
Reid, G.: A pharmacologically active substance in serum and platelets which stimulates suprarenal medulla. J. exp.Biol. Med. 26, 107 (1948).
Remde, W.: Der Einfluß von Heparin auf die Bildung der Blutthrombokinase. Z. ges. inn. Med. 11, 81 (1956).
Rheingold, J. J., and G. B. Wislocki: Histochemical methods applied to hematology. Blood 3, 641 (1948).
Ricci, M.: Modificazioni del sangue trattato con resina a scambio ionico (Amberlite I. R. 120). Sangue 25, 213 (1952).
Richter (1921): Zit. nach Maupin (1954).
Robb-Smith, A. H. T.: The Rubicon: Changing views on thrombosis and blood coagulation. Brit. med. Bull. 11, 70 (1955).
Robertis, E. de : Electron microscope observations of the platelet-fibrin relationship in blood clotting. Blood 10, 528 (1955).
P. Paseyro and M. Reissig: Electron microscopic studies of the action of thrombin on blood platelets. Blood 8, 587 (1953).
Rohr, K., u. F. Koller: Über die Abstammung der Thrombozyten. Klin. Wschr. 1936, 1549.
Roos, J.: Blood coagulation as a continuous process. Thromb. Diath. haem. 1, 471 (1957).
Rosenthal, R. L., O. H. Dreskin and N. Rosenthal: New hemophilialike disease caused by deficiency of a third plasma thromboplastin factor. Proc. Soc. exp. Biol. (N. Y.) 82, 171 (1953).
Roskam, J.: Contribution à l’étude de la physiologie normale et pathologique du globulin (plaquettes de Bizzozero). Arch. int. Physiol. 20, 240 (1923)
Roskam, J.: La synérèse des caillots fibrineux ne résulte pas d’une ,,fonction rétractante“ des globulins (plaquettes de Bizzozero). C. R. Soc. Biol. (Paris) 95, 1122 (1926).
Rothman, S., E. Adelson, A. Schwebeland R. D. Langdell: Adsorption of C14 dextran to human blood platelets and red blood cells in vitro. Vox Sang. (Basel) 1958 (to be published).
Rovatti, B.: Modificazioni di retrattilità del coagulo da trattamento con ultrasuoni. Sangue 1950, 3.
Roskam, J.: Indice d’adhésivité et agglutinogramme des plaquettes: nouvelles épreuves pour Tétude des affections hémorrhagipares et thrombogènes. Sang 22, 451 (1951).
Ruggieri, P., e G. Bolognesi: Gruppi A e B delle piastrine. Boll. Soc. Ital. Ematol. 2, 127 (1954).
Salmon, J.: Études immunoélectrophorétiques des antigènes plaquettaires humains.Schweiz. med. Wschr. 1958, 1047
Y. Bounameaux: Recherches sur l’antigènicité des plaquettes et du fibrinogène bovins. C. R. Soc. Biol. (Paris) 150, 2278 (1956).
Y. Bounameaux: Situation du fibrinogène décelé dans les thrombocytes bovins isolés et laves. Arch. int. Physiol. 65, 502 (1957).
M. Verstraete et Y. Bounameaux : Fibrinogène plaquettaire et afibrinogénémie. Arch. int. Physiol. 65, 632 (1957).
Saltzman, G. F.: The origin of blood platelets. Acta med. scand. Suppl. 1949, 221.
Salvidio, E.: Biochemical aspects of blood platelets. (Peptidase, acid and alkaline phosphatase activity in normal subjects, during menstruation and in some hemorrhagic disorders). Acta haemat. (Basel) 11, 301 (1954).
I. Pannaciulli and E. Bianchini : The action of coumarin anticoagulants and of vitamin K, on some enzymes of human blood platelets. 5. Kongr. Europ. Ges. Hämatol. 1956, S. 499.
Samuels, P. B., and D. R. Webster: The role of venous endothelium in the inception of thrombosis. Ann. Surg. 136, 422 (1952).
Sarkar, N. K.,G. Chaterjee ,R. Banerjee: Lipids in blood clotting. WayneUniversity 6. Ann. Symp. on blood. Vox Sang. (Basel) 1, 567 (1957).
Savitsky, J. P.: A plasma factor responsible for platelet adhesiveness and clot retraction acceleration. Blood 8,1091 (1953).
Schayer, R. W., and Y. Kobayashi: Histidin carboxylase and histamin-binding in rabbit platelets. Proc. Soc. exp.Biol. (N. Y.) 92, 653 (1956).
Schmidt, A.: Zur Blutlehre. Leipzig 1892.
Schneider, C. L., E. B. Claxton, C. H. Hughes and S. A. Johnson: Bovine platelets in large quantities. Properties and activities concerned with hemostasis. Amer. J. Physiol. 179, 236 (1954)
Schultze, M.: Ein heizbarer Objekttisch und seine Verwendung bei Untersuchungen des Blutes. Arch. mikr. Anat. 1, 1 (1865).
Seegers, W. H.: Activation of purified prothrombin. Proc. Soc. exp. Biol. (N. Y.) 72, 677 (1949).
Seegers, W. H.: Blood coagulation. Enzymes 2, 1106 (1951).
Seegers, W. H.: Coagulation of blood. Harvey Lect. 47, 180 (1951/52).
Seegers, W. H.: The purification of prothrombin. Rec. Progr. Chem. 13, 143 (1953).
Seegers, W. H.: Coagulation of the blood. Advanc. Enzymol. 16, 23 (1955).
Seegers, W. H.: Vue actuelle sur le rôle des plaquettes dans la coagulation sanguine. Sang 27, 866 (1956).
N. Alkjaersig: The preparation of prothrombin derivates and an indication of their properties. Arch. Biochem. 61, 1 (1956).
S. A. Johnson: Formation of autoprothrombin in solution containing purified prothrombin and purified platelet factor 3. Amer. J. Physiol. 181, 589 (1955).
S. A. Johnson : Conversion of prothrombin to autoprothrombin II (platelet cofactor II) and its relation to the blood clotting mechanism. Amer. J. Physiol. 184, 259 (1956).
C. Fell and N. Alkjaersig: Activation of purified prothrombin with platelets combined with various crude biochemical preparations. Amer. J. Physiol. 178, 1 (1954).
J. A. Penner: Quantitative concepts related to prothrombin and autoprothrombin I activity. Canad. J. Biochem. 34, 887 (1956).
R. H. Landaburu : Inhibition of prothrombin activation in sodium citrate solutions. Proc. Soc. exp. Biol. (N. Y.) 95, 710 (1957).
E. C. Loomis and J. M. Vandenbelt: Preparation of prothrombin products: Isolation of prothrombin and its properties. Arch. Biochem. 6, 85 (1945).
Seligmann, M., B. Goudemand, A. Janin, J. Bernard et P. Grabar: Etudes immunochimiques sur la présence de fibrinogène dans les extraits de plaquettes humaines lavées et dans certains extraits leucocytaires. Rev. Hémat. 12, 302 (1957).
Setna, S. S., and R. L. Rosenthal: Intermediate stages in platelet alterations during coagulation. Acta haemat. 19, 209 (1958).
Sharp, A. A.: Viscous metamorphosis of blood platelets: A study of the relationship to coagulation factors and fibrin formation. Brit. J. Haemat. 4, 28 (1958).
Sherry, S., and N. Alkjaersig: Studies on the fibrinolytic enzyme of human plasma. Thromb. Diath. haem. 1, 264 (1957).
Shinowara, G. Y.: Enzyme studies on human blood. XI. The isolation and characterization of thromboplastic cell and plasma components. J. Lab. clin. Med. 38, 11 (1951).
Shinowara, G. Y.: Thromboplastic cell component, the lipoprotein of erythrocytes and platelets. J. biol. Chem. 225, 63 (1957).
Shore, P. A., A. Pletscher, E. G. Tomich, R. Kuntzmanand B. B. Brodie: Release of blood platelet serotonin by reserpine and lack of effect on bleeding time. J. Pharmacol. 117, 232 (1956).
Shulman, N. R.: Studies on the inhibition of proteolytic enzymes by serum. II. Demonstration that separate proteolytic inhibitors exist in serum; their distinct properties and the specificity of their action. J. exp. Med. 95, 593 (1952).
Smith, C., M. Robinson and R. Tyson: Reaction oxydase as applied to megakaryocytes and platelets of the rat. Anat. Rec. 70, 139 (1938).
H. P., E. D. Warner and K. M. Brinkhous: Prothrombin deficiency and the bleeding tendency in liver injury (chloroform intoxication). J. exp. Med. 66, 801 (1937).
Sober, H. A., F. J. Gutter, M. M. Wyckoff and E. A. Peterson: Chromatography of proteins: II. Fractionation of serum protein on anion exchange cellulose. J. Amer. chem. Soc. 78, 756 (1956).
Soulier, J. B.: La consommation de la prothrombine pendant la coagulation du sang veineux et du sang capillaire. Nouvelle méthode d’investigation des syndromes hémorrhagiques. Rev. Hémat. 3, 302 (1948).
Soulier, J. B.: Activité thromboplastique du sang et du plasma conservé. Vox Sang. (Basel)., N. S. 1, 110 (1956).
Soulier, J. B.: A. G. Le Bolloch: Le test de tolérance à Théparine „in vitro“. Rev. Hémat. 5, 148 (1950).
Soulier, J. B.: The „in vitro“ heparin tolerance test in the control of dicumarol therapy. Acta med. scand. 140, 132 (1951).
M. J. Larrieu: Nouvelle méthode de diagnostic de Fhémophilie. Dosage des facteurs antihémophiliques A et B. Sang 24, 205 (1953).
O. Wartelle et D. Ménaché: Caractères différentiels des facteurs Hageman et PTA. Role du contact dans la phase initiale de la coagulation. Rev. franç. Ét. clin. biol. 3, 263 (1938).
Spaet, T. H.: Anticoagulants derived from blood platelets. J. appl. Physiol. 11, 119 (1957).
S. Bauer and S. Melamed: Hemorrhagic thrombocythemia. A blood coagulation disorder. Arch. intern. Med. 98, 377 (1956).
E. S. Garner: Studies on the storage lability of human antihemophilic factor.J. Lab. clin. Med. 46 (III) (1955).
Stefanini, M.: Autocatalytic formation of thrombin in blood coagulation. Acta med. scand. 140, 290 (1951).
Stefanini, M.: Mechanism of blood coagulation in normal and pathological conditions. Amer. J. Med. 14, 64 (1953).
E. W. Campbell: Studies on platelets: XII. Isolation and purification of the platelet thromboplastic factor; its physicochemical and biological properties in vitro and in vivo. Rev. Hémat. 9, 576 (1954).
W. Dameshek : Collection, preservation and transfusion of platelets. New Engl.J. Med. 248, 797 (1953).
W. Dameshek : The hemorrhagic disorders. New York u. London 1955
S. Kistner: Transfusion of platelets, platelet derivatives and platelet substitutes in the management of thrombocytopenie states. Proc. 6. Congr. Int. Soc. Blood Transfusion, Boston 1956, p. 378. Basel u. New York 1958.
N. Krinsky and S. I. Magalini: Studies on platelets. XIX: Carotenoid pigments in human platelets. J. Lab. clin. Med. 50, 225 (1957).
I. S. Murphy: Studies on platelets. XIV. Human platelets as source of anti- fibrinolysin. J. clin. Invest. 35, 355 (1956).
J. H. Silverberg: Studies on platelets: I. The relation of platelet agglutination to the coagulation mechanism. Amer. J. clin. Path. 21, 1030 (1951).
Stormorken, H.: The effect of trypsin on blood coagulation and the mechanism of its action. J. Lab. clin. Med. 48, 519 (1956).
Storti, E., S. Perugini and M. Soldati: Cytochemical investigations of normal mega-karyocytes and platelets. Acta haemat. (Basel) 10, 144 (1953).
Studer, A., u. A. Winterstein : Probleme der Blutgerinnung. I. Bestimmung des Heparins auf gerinnungsphysiologischem Wege. Helv. physiol. pharmacol. Acta 9, 6 (1951).
Szirmai, E., u. E. Bajusz: Der Zusammenhang der Thrombozyten-Succinodehydrase- Aktivität mit der Blutgerinnung. Verh. 5. Kongr. Europ. Ges. für Hämat., Freiburg 1955, S. 655.
Telfer, T. P., K. W. Denson and D. R. Wright: A „new“ coagulation defect. Brit. J. Haemat. 2, 308 (1956).
Tinacci, F., e C. Cessi: Alcune osservazioni sulla conglutinazione piastrinica dopo azione della jaluronidasa sulla struttura chimica delle piastrine. Boll. Soc. ital. Biol. sper. 28, 283 (1952).
Tocantins, L.: The mammalian blood platelet in health and disease. Medicine (Baltimore) 17, 155–258 (1938).
Trevan, J. W., and R. G. Macfarlane: Rep. med. Res. Coun. (Lond.) 1936/37, 143 (1938).
Tropeano, L., e E. Cacciola: Sulla attività tromboplastica delle cellule leuchemiche. Boll. Soc. ital. Ematol. 3, 2 (1955).
Tullis, J. L.: Separation and purification of leucocytes and platelets. Blood 7, 891 (1952).
Tullis, J. L.: Blood cells and plasma proteins. New York 1953-
Tullis, J. L.: Newer technics for the separation and fractionation of whole blood. N. Y. St. J. Med. 53, 525 (1953).
Tullis, J. L.: Trends in platelet research. N. Y. St. J. Med. 53, 542 (1953).
Tullis, J. L.: Preservation of platelets. 8. Conf. on plasma and cellular elements of the blood, Boston 1954.
Tullis, J. L., and P. Baudanza: Preservation of platelet concentrates for treatement of thrombo- cytopenic bleeding. 10. Conf. on plasma proteins and cellular elements of the blood. Boston 1956.
Turpini, R.: Further data on the evalution of platelet ac-globulin and its plasmatic origin. Experientia (Basel) 12, 220 (1956).
Valette, G., B. Maupin et H. Huidobro: Plaquettes sanguines et histaminase. C. R. Soc. Biol. (Paris) 145, 313 (1951).
Voit, K.: Zur Frage der Kernsubstanz in den Thrombozyten. Ärztl. Forsch. 2, 13 (1948).
H. Kempa: Über den Nachweis von echter Kernsubstanz in den Thrombozyten.Z. Biol. 95, 635 (1934).
Vries, S. I. de, H. K. Kettenborg and E. T. van der Pol: Verbandtussen een factor uit rode bloedcellen en de forming van thromboplastine. Ned. T. Geneesk. 99, 2967 (1955).
Vulpian, A.: Des corpuscules incoleurés et des leucocytes du sang. C. R. Soc. Biol.(Paris) 25, 49 (1873).
Wachstein, M.: The distribution of histochemically demonstrable glycogen in human blood and bone marrow cells. Blood 4, 54 (1949).
Wagner, R.: The estimation of glycogen in whole blood and white cells. Arch. Biochem. 11, 249 (1946).
N. Meyerriecks and C. Z. Berman : In vitro effects of x-Radiation on white blood cells and blood platelets.Blood 12, 733 (1957).
R. Sparaco : Enzyme studies on white blood cells and blood platelets. V. Dehydrogenase activity. Arch. Biochem. 61, 278 (1956).
Wallach, D. F. H., D. M. Surgenor and B. B. Steele: Calcium-lipid complexes in human platelets. Blood 13, 589 (1958).
Walther, G.: Über die Gerinnungsaktivität hämolysierter menschlicher Erythrocyten.Blut 2, 211 (1956).
Warburg, O.: Untersuchungen über die Oxydationsprozesse in Zellen. Münch. med.Wschr. 1911, 289.
Ware, A. G., J. L. Fahey and W. H. Seegers: Platelet extracts, fibrin formation and interaction of purified prothrombin and thromboplastin. Amer. J. Physiol. 154, 140 (1948).
W. H. Seegers : Serum ac-globulin; Formation from plasma ac-globulin: Role in blood coagulation; partial purification, properties and quantitative determination. Amer. J. Physiol. 152, 567 (1948).
Waugh, T. R., and D. W. Ruddick: A test for increased coagulability of the blood.Canad. med. Ass. J. 50, 547 (1944).
Wenckert, A., and J. M. Nilsson: Thromboplastin and Russel’s viper venom-Investigation on the activation of prothrombin. Scand. J. clin. Lab. Invest. 7, Suppl. 15 (1955).
Wilbrandt, W., E. F. Lüscher u. H. Asper: Der Einfluß von Thrombozytenproteinen auf die Permeabilität der Blutkapillaren. Helv. physiol. pharmacol. Acta 14, C 81 (1956).
Willi, H.: Über den Bau und die Funktion der Megakaryocyten und ihre Beziehungen zur thrombopenischen Purpura. Folia haemat. (Lpz.) 53, 426 (1935).
Wolf, P.: Lipid extracts of platelets and brain as substitutes for platelets in coagulation tests. Brit. J. Haemat. 2, 375 (1956).
Wolpers, C., u. H. Ruska: Strukturuntersuchungen zur Blutgerinnung. Klin. Wschr. 1939, 1077
Wright, H. P.: The adhesiveness of blood platelets in normal subjects with varying concentrations of anticoagulants. J. Path. Bact. 53, 255 (1941).
Wright, H. P.: Changes in the adhesiveness of blood platelets following parturition and surgical operations. J. Path. Bact. 54, 461 (1942).
Wright, H. P.: J. H., and G. R. Minot: The viscous metamorphosis of the blood platelets. J. exper. Med. 26, 395 (1917).
Zajicek, J.: Studies on the histogenesis of blood platelets. II. Quantitative determination of acetylcholinesterase activity in single megakaryocytes from various mammals. Acta haemat. (Basel) 15, 296 (1956).
Wright, H. P, N. Datta: Investigation on the acetylcholinesterase activity of erythrocytes, platelets and plasma in different animal species. Acta haemat. (Basel) 9, 115 (1953).
Zatti, P.: Sulle cause dell’agglutinazione delle piastrine nel sangue in via di coagulazione. Boll. Soc. ital. Biol. sper. 24, 22 (1948).
Zimmermann, U.: Über die Formgebilde des menschlichen Blutes in ihrem näheren Verhältnis zum Prozesse der Entzündungen und Eiterung. Rusts Mag. ges. Heilk. 66, 171 (1846).
Zingoni, U.: Sulla presenza di glicogena nei megacariociti e nelle piastrine del sangue. Arch. fisiol. 51, 216 (1951).
Zucker, M. B.: Platelet agglutination and vasocontriction as factors in spontaneous hemostasis in normal, thrombocytopenic, heparinized and hypoprothrombinemic blood. Amer. J. Physiol. 148, 275 (1947).
Zucker, M. B.,J. Borrelli: Reversible changes in platelet morphology produced by anticoagulants and by cold. Blood 9, 602 (1954).
Zucker, M. B.,J. Borrelli: Quantity, assay and release of serotonin in human platelets. J. appl. Physiol. 7, 425 (1955) (a).
Zucker, M. B.,Relationship of some blood clotting factors to serotonin release from washed platelets. J. appl. Physiol. 7, 432 (1955) (b).
Zucker, M. B.,B. K. Friedman and M. M. Rapport: Identification and quantitative determination of serotonin in blood platelets. Proc. Soc. exp. Biol. (N. Y.) 85, 282 (1954).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1959 Springer-Verlag OHG/Berlin · Göttingen · Heidelberg
About this chapter
Cite this chapter
Lüscher, E.F. (1959). Thrombocytenfaktoren. In: Krayer, O., Lehnartz, E., v. Muralt, A., Weber, H.H. (eds) Ergebnisse der Physiologie Biologischen Chemie und Experimentellen Pharmakologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-49773-5_1
Download citation
DOI: https://doi.org/10.1007/978-3-642-49773-5_1
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-49488-8
Online ISBN: 978-3-642-49773-5
eBook Packages: Springer Book Archive